Published in PLoS One on September 25, 2013
Migration and epithelial-to-mesenchymal transition of lung cancer can be targeted via translation initiation factors eIF4E and eIF4GI. Lab Invest (2016) 0.77
High Dietary Selenium Intake Alters Lipid Metabolism and Protein Synthesis in Liver and Muscle of Pigs. J Nutr (2016) 0.76
A novel route for preparing 5' cap mimics and capped RNAs: phosphate-modified cap analogues obtained via click chemistry. Chem Sci (2016) 0.75
Applications of Phosphate Modification and Labeling to Study (m)RNA Caps. Top Curr Chem (J) (2017) 0.75
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med (2004) 5.01
Cocrystal structure of the messenger RNA 5' cap-binding protein (eIF4E) bound to 7-methyl-GDP. Cell (1997) 4.75
Structure of translation factor eIF4E bound to m7GDP and interaction with 4E-binding protein. Nat Struct Biol (1997) 3.14
Structure, mechanism, and evolution of the mRNA capping apparatus. Prog Nucleic Acid Res Mol Biol (2001) 3.12
X-ray crystallography reveals a large conformational change during guanyl transfer by mRNA capping enzymes. Cell (1997) 3.07
Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res (2008) 3.02
Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J Clin Invest (2007) 3.01
RNA capping enzyme and DNA ligase: a superfamily of covalent nucleotidyl transferases. Mol Microbiol (1995) 2.85
Modification of the 5' end of mRNA. Association of RNA triphosphatase with the RNA guanylyltransferase-RNA (guanine-7-)methyltransferase complex from vaccinia virus. J Biol Chem (1980) 2.72
The polynucleotide ligase and RNA capping enzyme superfamily of covalent nucleotidyltransferases. Curr Opin Struct Biol (2004) 2.69
Structure of an mRNA capping enzyme bound to the phosphorylated carboxy-terminal domain of RNA polymerase II. Mol Cell (2003) 2.22
Covalent catalysis in nucleotidyl transfer reactions: essential motifs in Saccharomyces cerevisiae RNA capping enzyme are conserved in Schizosaccharomyces pombe and viral capping enzymes and among polynucleotide ligases. Proc Natl Acad Sci U S A (1994) 2.07
The role of the cap structure in RNA processing and nuclear export. Eur J Biochem (1997) 1.83
eIF4E, the mRNA cap-binding protein: from basic discovery to translational research. Biochem Cell Biol (2008) 1.78
Structural basis for nick recognition by a minimal pluripotent DNA ligase. Nat Struct Mol Biol (2007) 1.63
Eukaryotic mRNA capping enzyme-guanylate covalent intermediate. Proc Natl Acad Sci U S A (1982) 1.59
Recognition of mRNA cap structures by viral and cellular proteins. J Gen Virol (2005) 1.47
eIF4E: new family members, new binding partners, new roles. J Biol Chem (2009) 1.42
Characterization of human, Schizosaccharomyces pombe, and Candida albicans mRNA cap methyltransferases and complete replacement of the yeast capping apparatus by mammalian enzymes. J Biol Chem (1999) 1.38
Mutational analysis of the Saccharomyces cerevisiae ABD1 gene: cap methyltransferase activity is essential for cell growth. Mol Cell Biol (1996) 1.32
Expression and characterization of an RNA capping enzyme encoded by Chlorella virus PBCV-1. J Virol (1996) 1.22
Novel "anti-reverse" cap analogs with superior translational properties. RNA (2003) 1.18
The effect of "cap" analogs on reovirus mRNA binding to wheat germ ribosomes. Evidence for enhancement of ribosomal binding via a preferred cap conformation. J Biol Chem (1978) 1.18
The broad spectrum antiviral nucleoside ribavirin as a substrate for a viral RNA capping enzyme. J Biol Chem (2004) 1.15
Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo. Gene Ther (2010) 1.14
Autoregulation of ribosome biosynthesis by a translational response in fission yeast. Mol Cell Biol (2006) 1.12
Stopped-flow kinetic analysis of eIF4E and phosphorylated eIF4E binding to cap analogs and capped oligoribonucleotides: evidence for a one-step binding mechanism. J Biol Chem (2006) 1.04
Novel cap analogs for in vitro synthesis of mRNAs with high translational efficiency. RNA (2004) 1.04
Positive heat capacity change upon specific binding of translation initiation factor eIF4E to mRNA 5' cap. Biochemistry (2002) 1.02
Crystallographic and mass spectrometric characterisation of eIF4E with N7-alkylated cap derivatives. J Mol Biol (2007) 1.01
Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells. RNA (2007) 0.93
Expression of a synthetic gene for human cap binding protein (human IF-4E) in Escherichia coli and fluorescence studies on interaction with mRNA cap structure analogues. J Biochem (1991) 0.91
Cap in hand: targeting eIF4E. Cell Cycle (2009) 0.90
Synthesis of anti-reverse cap analogs (ARCAs) and their applications in mRNA translation and stability. Methods Enzymol (2007) 0.88
Inhibition of a metal-dependent viral RNA triphosphatase by decavanadate. Biochem J (2006) 0.87
Synthesis and biochemical properties of novel mRNA 5' cap analogs resistant to enzymatic hydrolysis. Nucleosides Nucleotides Nucleic Acids (2005) 0.85
The 2'-OH group at the group II intron terminus acts as a proton shuttle. Nat Chem Biol (2010) 0.84
Energetics of RNA binding by the West Nile virus RNA triphosphatase. FEBS Lett (2006) 0.83
Crystallization of the RNA guanylyltransferase of Chlorella virus PBCV-1. Acta Crystallogr D Biol Crystallogr (1997) 0.83
Kinetic and thermodynamic characterization of the RNA guanylyltransferase reaction. Biochemistry (2008) 0.82
X-ray studies of the messenger RNA 5' cap-binding protein (eIF4E) bound to 7-methyl-GDP. Nucleic Acids Symp Ser (1997) 0.81
Locked nucleic acid (LNA)-modified dinucleotide mRNA cap analogue: synthesis, enzymatic incorporation, and utilization. J Am Chem Soc (2009) 0.77
Novel dinucleoside 5',5'-triphosphate cap analogues. Synthesis and affinity for murine translation factor eIF4E. Nucleosides Nucleotides Nucleic Acids (2005) 0.77
Thermodynamics of 7-methylguanosine cation stacking with tryptophan upon mRNA 5' cap binding to translation factor eIF4E. Nucleosides Nucleotides Nucleic Acids (2003) 0.77
Synthesis and biological evaluation of trimethyl-substituted cap analogs. Bioorg Med Chem Lett (2008) 0.77
The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure. RNA (2009) 1.58
Developing three-dimensional models of putative-folding intermediates of the HDV ribozyme. Structure (2010) 1.49
Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C Virus. J Biol Chem (2005) 1.17
The broad spectrum antiviral nucleoside ribavirin as a substrate for a viral RNA capping enzyme. J Biol Chem (2004) 1.15
Initial binding of the broad spectrum antiviral nucleoside ribavirin to the hepatitis C virus RNA polymerase. J Biol Chem (2003) 1.01
Characterization of the metal ion binding properties of the hepatitis C virus RNA polymerase. J Biol Chem (2002) 0.98
Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells. J Hepatol (2007) 0.97
Identification of proteins from prunus persica that interact with peach latent mosaic viroid. J Virol (2009) 0.90
Ribavirin is not a functional mimic of the 7-methyl guanosine mRNA cap. RNA (2005) 0.90
Monitoring of an RNA multistep folding pathway by isothermal titration calorimetry. Biophys J (2009) 0.89
Investigating the role of metal ions in the catalytic mechanism of the yeast RNA triphosphatase. J Biol Chem (2003) 0.87
Inhibition of a metal-dependent viral RNA triphosphatase by decavanadate. Biochem J (2006) 0.87
The RNA strands of the plus and minus polarities of peach latent mosaic viroid fold into different structures. RNA (2010) 0.86
Mapping studies of the Peach latent mosaic viroid reveal novel structural features. Mol Plant Pathol (2011) 0.86
Examination of the folding pathway of the antigenomic hepatitis delta virus ribozyme reveals key interactions of the L3 loop. RNA (2006) 0.84
Elements in the canine distemper virus M 3' UTR contribute to control of replication efficiency and virulence. PLoS One (2012) 0.84
Effect of metal ion binding on the structural stability of the hepatitis C virus RNA polymerase. J Biol Chem (2004) 0.83
Energetics of RNA binding by the West Nile virus RNA triphosphatase. FEBS Lett (2006) 0.83
Metal ion-binding studies highlight important differences between flaviviral RNA polymerases. Biochim Biophys Acta (2008) 0.82
Kinetic and thermodynamic characterization of the RNA guanylyltransferase reaction. Biochemistry (2008) 0.82
The RNA capping machinery as an anti-infective target. Wiley Interdiscip Rev RNA (2010) 0.81
Characterization of the DNA- and dNTP-binding activities of the human cytomegalovirus DNA polymerase catalytic subunit UL54. Biochem J (2007) 0.81
Thermodynamics of ligand binding by the yeast mRNA-capping enzyme reveals different modes of binding. Biochem J (2004) 0.80
Magnesium-binding studies reveal fundamental differences between closely related RNA triphosphatases. Nucleic Acids Res (2007) 0.79
Nucleotide analogs and molecular modeling studies reveal key interactions involved in substrate recognition by the yeast RNA triphosphatase. Nucleic Acids Res (2009) 0.79
Insights into the molecular determinants involved in cap recognition by the vaccinia virus D10 decapping enzyme. Nucleic Acids Res (2010) 0.79
Programming a highly structured ribozyme into complex allostery using RNA oligonucleotides. ACS Chem Biol (2012) 0.79
Deciphering the molecular basis for nucleotide selection by the West Nile virus RNA helicase. Nucleic Acids Res (2010) 0.79
Characterization of the vaccinia virus D10 decapping enzyme provides evidence for a two-metal-ion mechanism. Biochem J (2009) 0.78
A novel ribozyme-based prophylaxis inhibits influenza A virus replication and protects from severe disease. PLoS One (2011) 0.78
Characterization of the RNA binding energetics of the Candida albicans poly(A) polymerase. Yeast (2007) 0.77
Analysis of decapping scavenger cap complex using modified cap analogs reveals molecular determinants for efficient cap binding. FEBS J (2013) 0.76
Virtual high-throughput screening identifies mycophenolic acid as a novel RNA capping inhibitor. PLoS One (2011) 0.75
The immunosuppressive agent mizoribine monophosphate is an inhibitor of the human RNA capping enzyme. PLoS One (2013) 0.75
[Synergy between transcription and mRNA processing events]. Med Sci (Paris) (2006) 0.75
Further characterization and determination of the single amino acid change in the tsI138 reovirus thermosensitive mutant. Can J Microbiol (2012) 0.75